Novavax, Inc. short interest in 2021
In 2021, Novavax, Inc.'s disclosed short interest ran from 10.95% of shares outstanding on 15 Jan 2021 to 11.80% on 31 Dec 2021, a change of +0.85 percentage points. The year's high was 11.80% on 31 Dec 2021 and its low 5.81% on 31 Mar 2021, averaging 8.68% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.55 days on 28 May 2021. Full history: Novavax, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 10.95% (15 Jan 2021)
- End of year
- 11.80% (31 Dec 2021)
- Change
- +0.85 pp
- High
- 11.80% (31 Dec 2021)
- Low
- 5.81% (31 Mar 2021)
- Average
- 8.68%
- Highest days to cover
- 2.55 (28 May 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 10.95% | 2.36 | |
| 29 Jan 2021 | 9.74% | 1.83 | |
| 12 Feb 2021 | 9.63% | 1.10 | |
| 26 Feb 2021 | 7.22% | 2.03 | |
| 15 Mar 2021 | 6.70% | 1.14 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 5.81% | 1.54 | |
| 15 Apr 2021 | 6.36% | 1.93 | |
| 30 Apr 2021 | 6.01% | 1.43 | |
| 14 May 2021 | 7.07% | 1.00 | 10-Q filed, results (8-K) |
| 28 May 2021 | 7.84% | 2.55 | |
| 15 Jun 2021 | 7.82% | 1.27 | |
| 30 Jun 2021 | 8.20% | 1.24 | |
| 15 Jul 2021 | 8.17% | 1.91 | |
| 30 Jul 2021 | 7.95% | 1.46 | |
| 13 Aug 2021 | 9.64% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 8.16% | 1.47 | |
| 15 Sep 2021 | 8.97% | 1.49 | |
| 30 Sep 2021 | 8.15% | 1.55 | |
| 15 Oct 2021 | 8.27% | 1.25 | |
| 29 Oct 2021 | 11.07% | 1.27 | |
| 15 Nov 2021 | 11.39% | 1.48 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 10.24% | 1.52 | |
| 15 Dec 2021 | 11.07% | 1.65 | |
| 31 Dec 2021 | 11.80% | 1.09 |
See also: Novavax, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.